Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
International Journal of Surgery (London, England)
|
July 3, 2024
Do low skeletal muscle bulk and disturbed body fat mass impact tumor recurrence in stage I/II hepatocellular carcinoma undergoing surgery? An observational cohort study
Chao-Wei Lee, Hsin-I Tsai, Hsiao-Mei Hsu, et al.
Hepatology (Baltimore, Md.)
|
November 25, 2017
Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice
Jei-Ming Peng, Rabindranath Bera, Chih-Yung Chiou, et al.
Journal of Personalized Medicine
|
December 24, 2021
The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
Hao-Chien Hung, Po-Jung Hsu, Ting-Chang Chang, et al.
Journal of Cancer Research and Clinical Oncology
|
July 20, 2024
Does autoimmune disease impair the survival of hepatocellular carcinoma patients undergoing liver resection? A multi-institutional observational study
Chao-Wei Lee, Hsing-Yu Chen, Ping-Han Tsai, et al.
Cancers
|
February 15, 2022
Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
Abner Herbert Lim, Jason Yongsheng Chan, Ming-Chin Yu, et al.
Biomedical Journal
|
April 17, 2019
Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy
Hsu-Huan Chou, Wen-Ling Kuo, Chi-Chang Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 24, 2025
Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening
Chun-Lin Yang, Yi-Wen Wu, Huang-Ju Tu, et al.
Science Translational Medicine
|
October 20, 2017
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
Alvin W T Ng, Song Ling Poon, Mi Ni Huang, et al.
Journal of Hepatology
|
March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage
Chun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
World Journal of Gastroenterology
|
August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
Chun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
International Journal of Surgery (London, England)
|
July 3, 2024
Do low skeletal muscle bulk and disturbed body fat mass impact tumor recurrence in stage I/II hepatocellular carcinoma undergoing surgery? An observational cohort study
Chao-Wei Lee, Hsin-I Tsai, Hsiao-Mei Hsu, et al.
Hepatology (Baltimore, Md.)
|
November 25, 2017
Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice
Jei-Ming Peng, Rabindranath Bera, Chih-Yung Chiou, et al.
Journal of Personalized Medicine
|
December 24, 2021
The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
Hao-Chien Hung, Po-Jung Hsu, Ting-Chang Chang, et al.
Journal of Cancer Research and Clinical Oncology
|
July 20, 2024
Does autoimmune disease impair the survival of hepatocellular carcinoma patients undergoing liver resection? A multi-institutional observational study
Chao-Wei Lee, Hsing-Yu Chen, Ping-Han Tsai, et al.
Cancers
|
February 15, 2022
Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers
Abner Herbert Lim, Jason Yongsheng Chan, Ming-Chin Yu, et al.
Biomedical Journal
|
April 17, 2019
Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy
Hsu-Huan Chou, Wen-Ling Kuo, Chi-Chang Yu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
March 24, 2025
Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening
Chun-Lin Yang, Yi-Wen Wu, Huang-Ju Tu, et al.
Science Translational Medicine
|
October 20, 2017
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
Alvin W T Ng, Song Ling Poon, Mi Ni Huang, et al.
Journal of Hepatology
|
March 24, 2009
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage
Chun-Jen Liu, Po-Huang Lee, Deng-Yn Lin, et al.
World Journal of Gastroenterology
|
August 30, 2014
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
Chun-Jen Liu, Juliana Chang, Po-Huang Lee, et al.
Page
of 12